| identifier | PRJEB32719 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| type | bioproject | ||||||||||||
| sameAs |
|
||||||||||||
| organism | |||||||||||||
| title | Whole-exome sequencing of genomic DNA from patient-derived melanoma cell lines resistant to either vemurafenib (PLX) or trametinib (TRA). | ||||||||||||
| description | Whole-exome sequencing was performed on DNA samples extracted from seven melanoma cell lines resistant to either vemurafenib (BRAF V600E inhibitor) or trametinib (MEK1/2 inhibitor). The aim of the experiment was to search for genetic alterations responsible for phenotypic diversity of melanoma cell lines reported at the level of cell morphology, activity of signaling pathways essential for melanoma development and progression, and resistance to targeted therapeutics. | ||||||||||||
| data type | Other | ||||||||||||
| organization |
|
||||||||||||
| publication | |||||||||||||
| properties ▽ |
{...}
|
||||||||||||
| dbXrefs |
|
||||||||||||
| distribution | JSONJSON-LD | ||||||||||||
| Download |
|
||||||||||||
| status | public | ||||||||||||
| visibility | unrestricted-access | ||||||||||||
| dateCreated | 2019-06-17T00:00:00Z | ||||||||||||
| dateModified | 2019-06-17T00:00:00Z | ||||||||||||
| datePublished |